EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 27 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $5,000 | – | 26,383 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 66,666 | $660,000 | 0.02% |
Radcliffe Capital Management, L.P. | 33,333 | $330,000 | 0.01% |
Altium Capital Management LP | 133,333 | $9,000 | 0.00% |
Arena Investors LP | 94,516 | $6,000 | 0.00% |
Granite Point Capital Management, L.P. | 133,332 | $9,000 | 0.00% |
COWEN AND COMPANY, LLC | 122,257 | $8,000 | 0.00% |
683 Capital Management, LLC | 200,000 | $13,000 | 0.00% |
JANE STREET GROUP, LLC | 27,670 | $2,000 | 0.00% |
PRICE T ROWE ASSOCIATES INC /MD/ | 22,697 | $2,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 159,633 | $5 | 0.00% |